Skip to main content
. 2016 Aug 5;12(4):2307–2318. doi: 10.3892/ol.2016.4954

Table V.

Genotypes of LRP5 single-nucleotide polymorphisms in squamous cell carcinoma patients and controls.

Genotype SCC n=169 (%) Controls n=500 (%) P-value OR (95% CI) Male SCCs n=161 (%) Male controls n=259 (%) P-value OR (95% CI) Female SCCs n=8 (%) Female controls n=240 (%) P-value OR (95% CI)
Rs4930573
  CC 117 (69.2) 324 (64.8) 1 (Reference) 112 (69.6) 169 (65.3) 1 (Reference) 5 (62.5) 154 (64.2) 1 (Reference)
  GG 2 (1.2) 16 (3.2) 1 (0.6) 6 (2.3) 1 (12.5) 10 (4.2)
  CG 50 (29.6) 160 (32.0) 0.28 48 (29.8) 84 (32.4) 0.33 2 (25.0) 76 (31.6) 0.52
  CG+GG 52 (30.8) 176 (35.2) 0.29 0.82 (0.56–1.19) 49 (30.4) 90 (34.7) 0.36 0.82 (0.54–1.25) 3 (37.5) 86 (35.8) 0.92 1.07 (0.25–4.61)
Rs312009
  CC 103 (60.9) 291 (0.582) 1 (Reference) 96 (59.6) 145 (56.0) 1 (Reference) 7 (87.5) 146 (60.8) 1 (Reference)
  TT 7 (4.1) 36 (0.072) 7 (4.4) 15 (5.8) 0 (0.0) 21 (8.7)
  CT 59 (34.9) 173 (0.346) 0.37 58 (36.0) 99 (38.2) 0.69 1 (12.5) 73 (30.4) 0.30
  TT+CT 66 (39.1) 209 (0.418) 0.53 1.12 (0.79–1.60) 65 (40.4) 114 (44.0) 0.46 1.16 (0.78–1.73) 1 (12.5) 94 (39.2) 0.13 4.51 (0.55–37.22)
Rs312014
  CC 58 (34.3) 145 (29.0) 1 (Reference) 56 (34.8) 74 (28.6) 1 (Reference) 2 (25.0) 71 (29.6) 1(Reference)
  CG 81 (47.9) 240 (48.0) 76 (47.2) 125 (48.3) 5 (62.5) 114 (47.5)
  GG 30 (17.8) 115 (23.0) 0.25 29 (18.0) 60 (23.2) 0.29 1 (12.5) 55 (22.9) 0.67
  GG+CG 111 (65.7) 355 (71.0) 0.19 1.28 (0.88–1.86) 105 (65.2) 185 (71.4) 0.18 1.33 (0.882.03) 6 (75.0) 169 (70.4) 0.78 1.26 (0.25–6.40)
Rs3781590
  CC 131 (77.5) 402 (80.4) 1 (Reference) 126 (78.3) 218 (84.2) 1 (Reference) 5 (62.5) 183 (76.2) 1 (Reference)
  TT 0 (0.0) 3 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 3 (1.3)
  CT 38 (22.5) 95 (19.0) 0.38 35 (21.7) 41(15.8) 0.13 3 (37.5) 54 (22.4) 0.59
  TT+CT 38 (22.5) 98 (19.6) 0.42 0.84 (0.55–1.28) 35 (21.7) 41 (15.8) 0.13 0.68 (0.41–1.12) 3 (37.5) 57 (23.7) 0.37 0.52 (0.12–2.24)
Rsa312015
  GG 69 (40.8) 181 (36.2) 1 (Reference) 65 (40.4) 94 (36.3) 1 (Reference) 4 (50.0) 87 (36.2) 1 (Reference)
  CC 26 (15.4) 80 (16.0) 24 (14.9) 40 (15.4) 2 (25.0) 40 (16.7)
  CG 74 (43.8) 239 (47.8) 0.55 72 (44.7) 125 (48.3) 0.70 2 (25.0) 113 (47.1) 0.47
  CC+CG 100 (59.2) 319 (63.8) 0.28 1.21 (0.85–1.74) 96 (59.6) 165 (63.7) 0.40 1.19 (0.79–1.78) 4 (0.500) 153 (63.7) 0.43 1.76 (0.43–7.21)
Rs491347
  TT 112 (66.3) 311 (62.2) 1 (Reference) 107 (66.5) 149 (57.5) 1 (Reference) 5 (62.5) 161 (67.1) 1 (Reference)
  CC 7 (4.1) 16 (3.2) 6 (3.7) 11 (4.3) 1 (12.5) 5 (2.1)
  CT 50 (29.6) 173 (34.6) 0.45 48 (29.8) 99 (38.2) 0.19 2 (25.0) 74 (30.8) 0.17
  CC+CT 57 (33.7) 189 (37.8) 0.34 1.19 (0.83–1.72) 54 (33.5) 110 (42.5) 0.07 1.46 (0.97–2.20) 3 (37.5) 79 (32.9) 0.79 0.82 (0.19–3.51)
Rs1784235
  TT 112 (66.3) 312 (62.4) 1 (Reference) 108 (67.1) 149 (57.5) 1 (Reference) 4 (50.0) 162 (67.5)   1 (Reference)
  CC 7 (4.1) 16 (3.2) 6 (3.7) 11 (4.2) 1 (12.5) 5 (2.1)
  CT 50 (29.6) 172 (34.4) 0.47 47 (29.2) 99 (38.2) 0.14 3 (37.5) 73 (30.4) 0.14
  CC+CT 57 (33.7) 188 (37.6) 0.37 1.18 (0.82–1.71) 53 (32.9) 110 (42.5) 0.05 1.50 (1.00–2.27) 4 (50.0) 78 (32.5) 0.30 0.48 (0.12–1.98)
Rs648438
  TT 145 (85.8) 395 (79.0) 1 (Reference) 140 (87.0) 205 (79.2) 1 (Reference) 5 (62.5) 189 (78.7) 1 (Reference)
  CC 3 (1.8) 8 (1.6) 3 (1.9) 4 (1.5) 0 (0.0) 4 (1.7)
  CT 21 (12.4) 97 (19.4) 0.12 18 (11.1) 50 (19.3) 0.09 3 (37.5) 47 (19.6) 0.44
  CC+CT 24 (14.2) 105 (21.0) 0.05 1.61 (0.9–2.60) 21 (13.0) 54 (20.8) 0.04 1.77 (1.02–3.04) 3 (37.5) 51 (21.3) 0.27 0.45 (0.10–1.95)
Rs3736228
  CC 110 (65.1) 306 (61.2) 1 (Reference) 106 (65.8) 146 (56.4) 1 (Reference) 4 (50.0) 159 (66.2) 1 (Reference)
  TT 7 (4.1) 16 (3.2) 6 (3.7) 11 (4.2) 1 (12.5) 5 (2.1)
  CT 52 (30.8) 178 (35.6) 0.47 49 (30.5) 102 (39.4) 0.15 3 (37.5) 76 (31.7) 0.14
  TT+CT 59 (34.9) 194 (38.8) 0.36 1.18 (0.82–1.70) 55 (34.2) 113 (43.6) 0.05 1.49 (0.99–2.24) 4 (50.0) 81 (33.8) 0.34 0.51 (0.12–2.09)
Rs624947
  AA 122 (72.2) 368 (73.6) 1 (Reference) 117 (72.7) 202 (78.0) 1 (Reference) 5 (62.5) 165 (68.8) 1 (Reference)
  AG 46 (27.2) 123 (24.6) 43 (26.7) 53 (20.5) 3 (37.5) 70 (29.2)
  GG 1 (0.6) 9 (1.8) 0.45 1 (0.6) 4 (1.5) 0.25 0 (0.0) 5 (2.1) 0.82
  AG+GG 47 (27.8) 132 (26.4) 0.72 0.93 (0.63–1.38) 44 (27.3) 57 (22.0) 0.21 0.75 (0.48–1.18) 3 (37.5) 75 (31.3) 0.71 0.76 (0.18–3.25)
Rs607887
  CC 101 (59.8) 278 (55.6) 1 (Reference) 97 (60.2) 134 (51.7) 1 (Reference) 4 (50.0) 143 (59.6) 1 (Reference)
  TT 9 (5.3) 26 (5.2) 8 (5.0) 16 (6.2) 1 (12.5) 10 (4.2)
  CT 59 (34.9) 196 (39.2) 0.61 56 (34.8) 109 (42.1) 0.23 3 (37.5) 87 (36.2) 0.51
  TT+CT 68 (40.2) 222 (44.4) 0.35 1.19(0.83–1.69) 64 (39.8) 125 (48.3) 0.09 1.41 (0.95–2.11) 4 (50.0) 97 (40.4) 0.59 0.68 (0.17–2.78)

LRP5, low-density lipoprotein receptor-related protein 5; SCC, squamous cell carcinoma; OR, odds ratio; CI, confidence interval.